Found: 10
Select item for more details and to access through your institution.
Acute poisoning after oral intake of a toluene-containing paint thinner.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Overestimation of the effect of (fos)aprepitant on intravenous dexamethasone pharmacokinetics requires adaptation of the guidelines for children with chemotherapy-induced nausea and vomiting.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 12, p. 9991, doi. 10.1007/s00520-022-07423-6
- By:
- Publication type:
- Article
A simple extemporaneous oral suspension of aprepitant yields sufficient pharmacokinetic exposure in children.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 899, doi. 10.1177/10781552221089243
- By:
- Publication type:
- Article
Validation of techniques for the prediction of carboplatin exposure: Application of Bayesian methods<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2000, v. 67, n. 6, p. 621, doi. 10.1067/mcp.2000.106827
- By:
- Publication type:
- Article
Determination of ruthenium originating from the investigational anti-cancer drug NAMI-A in human plasma ultrafiltrate, plasma, and urine by inductively coupled plasma mass spectrometry.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2007, v. 21, n. 9, p. 1521, doi. 10.1002/rcm.2985
- By:
- Publication type:
- Article
Quantitative analysis of D-24851, a novel anticancer agent, in human plasma and urine by liquid chromatography coupled with tandem mass spectrometry.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2004, v. 18, n. 13, p. 1465, doi. 10.1002/rcm.1493
- By:
- Publication type:
- Article
A phase 0 clinical trial of novel candidate extended-release formulations of capecitabine.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 49, n. 3, p. 201, doi. 10.1007/s002800100371
- By:
- Publication type:
- Article
Reduction of cyclophosphamide bioactivation by thioTEPA: critical sequence-dependency in high-dose chemotherapy regimens.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 2, p. 119, doi. 10.1007/s002800000132
- By:
- Publication type:
- Article
Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 1, p. 61, doi. 10.1046/j.1365-2125.2001.01301.x
- By:
- Publication type:
- Article